Original Research

Business, Original Research

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients

Tia Goss Sawhney, DrPH, FSA, MAAA, Bruce S. Pyenson, FSA, MAAA, David Rotter, PhD, Michele Berrios, Judy Yee, MD

Business, Original Research

Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation

Derek Ems, MPH, Sharanya Murty, PhD, Bryan Loy, MD, Judith Gallagher, MBA, Laura E. Happe, PharmD, MPH, Teresa L. Rogstad, MPH, Debra Finnel, Jimmy D. Fernandez, MD, MBA

Business, Original Research

Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes

Ivar S. Jensen, MBA, Elizabeth Wu, MPH, Naomi C. Sacks, PhD, Philip L. Cyr, MPH, Karen C. Chung, PharmD, MS

Original Research, Regulatory

Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015

Xiaomeng Yue, BPharm, MS, Jeff Jianfei Guo, MS, BPharm, PhD, Patricia R. Wigle, PharmD

Stakeholder Perspective

The Importance and Benefits of Smoking-Cessation Therapy

by Jack E. Fincham, PhD, RPh

Clinical, Original Research

Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia

Craig White, PhD, Winghan Jacqueline Kwong, PharmD, PhD, Hilary Armstrong, PhD, Michael Behling, Jeffrey Niemira, Kathy Lang, PhD

Stakeholder Perspective

Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage

by F. Randy Vogenberg, PhD, FASHP

Business, Original Research

Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies

Vincent J. Willey, PharmD, Sheldon Kong, PhD, Bingcao Wu, MS, Amit Raval, PhD, Todd Hobbs, MD, Andrea Windsheimer, PharmD, Gaurav Deshpande, MS, PhD, Ozgur Tunceli, PhD, Brian Sakurada, PharmD, Jonathan R. Bouchard, MS, RPh

Clinical, Original Research

Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States

Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD, Askal A. Ali, PhD

Stakeholder Perspective

The Challenge of Maintaining Vascular Access in Patients with End-Stage Renal Disease

by Raymond L. Singer, MD, MMM, CPE

Business, Original Research

The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women

Christine Ferro, CHFP, Bruce S. Pyenson, FSA, MAAA, Jocelyn Lau, MPH, Mona Kelkar, MBA, Nancy Phillips, MD, Chi-Wei Lu, PhD, Percy Yeung, PhD, Gloria Bachmann, MD

Stakeholder Perspective

Interventions to Reduce Avoidable Pregnancy-Related Emergency Department Visits

by Eliza Ng, MD

Business, Original Research

Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease

Michele Wilson, MSPH, Aaron Lucas, PhD, MPH, Ann Cameron, MA, PhD, Michelle Luo, PhD

Clinical, Original Research

Prior Authorization for Elective Diagnostic Catheterization: The Value of Reviewers in Cases with Clinical Ambiguity

Adam C. Powell, PhD, Stephen E. Price, DPT, MBA, Khoa Nguyen, MS, Gary L. Smith, MS, James W. Long, BSBA, Uday U. Deshmukh, MD, MPH

Stakeholder Perspective

Standardized Documentation Can Improve Diagnostic Testing Decisions for Patients with Cardiovascular Disease

by Raymond L. Singer, MD, MMM, CPE

1
2
3
4
5
6
7

Page 4 of 8
Results 31 - 40 of 80

Copyright © Engage Healthcare Communications, LLC. All rights reserved.